Saracco, G <br/><br/>
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jul 2001 
 - 133-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1053/jhep.2001.25636  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage<br/>Treatment Outcome<br/>Viremia